DE69716485D1 - Taxol enthaltende pharmazeutische injektionslösung - Google Patents
Taxol enthaltende pharmazeutische injektionslösungInfo
- Publication number
- DE69716485D1 DE69716485D1 DE69716485T DE69716485T DE69716485D1 DE 69716485 D1 DE69716485 D1 DE 69716485D1 DE 69716485 T DE69716485 T DE 69716485T DE 69716485 T DE69716485 T DE 69716485T DE 69716485 D1 DE69716485 D1 DE 69716485D1
- Authority
- DE
- Germany
- Prior art keywords
- taxol
- injection solution
- containing pharmaceutical
- tromethamine
- pharmaceutical injection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IB1997/000623 WO1998053810A1 (en) | 1997-05-30 | 1997-05-30 | Pharmaceutical injection solution containing taxol |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69716485D1 true DE69716485D1 (de) | 2002-11-21 |
DE69716485T2 DE69716485T2 (de) | 2003-04-10 |
Family
ID=11004572
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69716485T Expired - Lifetime DE69716485T2 (de) | 1997-05-30 | 1997-05-30 | Taxol enthaltende pharmazeutische injektionslösung |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0998279B1 (de) |
AT (1) | ATE226070T1 (de) |
DE (1) | DE69716485T2 (de) |
WO (1) | WO1998053810A1 (de) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002043765A2 (en) * | 2000-11-28 | 2002-06-06 | Transform Pharmaceuticals, Inc. | Pharmaceutical formulations comprising paclitaxel, derivatives, and pharmaceutically acceptable salts thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5157049A (en) * | 1988-03-07 | 1992-10-20 | The United States Of America As Represented By The Department Of Health & Human Services | Method of treating cancers sensitive to treatment with water soluble derivatives of taxol |
FR2678833B1 (fr) * | 1991-07-08 | 1995-04-07 | Rhone Poulenc Rorer Sa | Nouvelles compositions pharmaceutiques a base de derives de la classe des taxanes. |
AU5553894A (en) * | 1992-11-27 | 1994-06-22 | F.H. Faulding & Co. Limited | Injectable taxol composition |
FR2698543B1 (fr) * | 1992-12-02 | 1994-12-30 | Rhone Poulenc Rorer Sa | Nouvelles compositions à base de taxoides. |
-
1997
- 1997-05-30 DE DE69716485T patent/DE69716485T2/de not_active Expired - Lifetime
- 1997-05-30 AT AT97921986T patent/ATE226070T1/de active
- 1997-05-30 EP EP97921986A patent/EP0998279B1/de not_active Expired - Lifetime
- 1997-05-30 WO PCT/IB1997/000623 patent/WO1998053810A1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
EP0998279A1 (de) | 2000-05-10 |
WO1998053810A1 (en) | 1998-12-03 |
ATE226070T1 (de) | 2002-11-15 |
DE69716485T2 (de) | 2003-04-10 |
EP0998279B1 (de) | 2002-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2171469T3 (es) | Composicion administrada por via nasal y preparacion que la contiene. | |
IT1270594B (it) | Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida | |
CY2562B1 (en) | Pharmaceutical injectable solution of paracetamol and combinations of paracetamol with other active substances | |
DE69331409D1 (de) | Oral 1alpha-hydroxyprevitamin d | |
EA200200431A1 (ru) | Фармацевтические композиции, обеспечивающие повышенные концентрации лекарства | |
ES2192234T3 (es) | Composiciones farmaceuticas parenterales conteniendo sales de amonioalquilo de acidos 2-arilpropionicos. | |
KR910000703A (ko) | 테트라졸 자극성 아미노산 수용체의 길항물질 | |
RS50768B (sr) | Režim doziranja i farmaceutska formulacija za urgentnu zaštitu | |
SE9002500D0 (sv) | Farmaceutisk, nac-innehaallande komposition foer oral administrering | |
ATE50499T1 (de) | Pharmazeutische zusammensetzungen mit gehalt an flavanolignanen und phospholipiden als wirkstoffe. | |
ID22763A (id) | Komposisi penstabil tibolon | |
ES2139842T3 (es) | Uso de la melatonina para tratar a pacientes que sufren drogodependencia. | |
SE9301877D0 (sv) | In situ gel for therapeutic use | |
DE69716485D1 (de) | Taxol enthaltende pharmazeutische injektionslösung | |
KR910007523A (ko) | 과콜레스테린혈증, 과지방혈증 및 혈전색전증 질병 치료용 토코트리엔올 | |
KR970073583A (ko) | 탁속을 함유한 주사용 약제 조성물 | |
KR960003717A (ko) | 항암제에 의해 유발되는 말초신경병의 예방에 유용한 의약의 제조를 위한 엘리프로딜 및 그 거울상이성질체의 이용 | |
RU94032792A (ru) | Применение 5нтiа - антагонистов для прекращения использования табака | |
AR007058A1 (es) | Uso de interferon en medicamentos y composiciones para contacto oromucosal | |
KR960003718A (ko) | 말초신경병 및 중추신경변성병의 치료에 유용한 의약의 제조를 위한 이펜프로딜 및 그 부분입체이성질체의 이용 | |
KR910002434A (ko) | 레티노이드의 용도 | |
KR870005642A (ko) | 디플루니살과 트로메타민의 혼합물 | |
KR920019356A (ko) | 약제학적 조성물 및 그 제조방법 | |
KR880000094A (ko) | 위염치료제 | |
EA200101157A1 (ru) | 14β-H-СТЕРОЛЫ, СОДЕРЖАЩИЕ ИХ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ И ПРИМЕНЕНИЕ ЭТИХ ПРОИЗВОДНЫХ ДЛЯ ПРИГОТОВЛЕНИЯ ЛЕКАРСТВЕННЫХ СРЕДСТВ, РЕГУЛИРУЮЩИХ МЕЙОЗ |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |